There are 449 resources available
AI-based tools for differential diagnosis of lung nodules
Presenter: Reinhard Buttner
Session: AI application in diagnosis and pathology
Resources:
Slides
Webcast
Optimising first-line treatment strategies in driver-positive lung cancer
Presenter: Pilar Garrido Lopez
Session: Best therapies with driver mutations in lung cancer
Resources:
Slides
Webcast
Common themes in targeted therapy resistance across oncogene-driven NSCLC
Presenter: Sun Min Lim
Session: Best therapies with driver mutations in lung cancer
Resources:
Slides
Webcast
What can patient organisations do to address the impact of brain metastases?
Presenter: Shani Shilo
Session: Challenges of brain metastases: The patient’s perspective (Patient advocacy session)
Resources:
Slides
Webcast
Are we there yet? The next wave of AI
Presenter: Teodora Radonic
Session: AI application in diagnosis and pathology
Resources:
Slides
Webcast
New targets, new drugs: Promising therapies for KRAS (including non-G12C mutations), HER2, NRG1 and other new targets
Presenter: Joop De Langen
Session: Best therapies with driver mutations in lung cancer
Resources:
Slides
Webcast
Advances in targeting brain metastases
Presenter: Matthias Guckenberger
Session: Challenges of brain metastases: The patient’s perspective (Patient advocacy session)
Resources:
Slides
Webcast
Second vote and conclusions/discussion
Presenter: Sonja Loges
Session: Using immunotherapy with immunosuppression?
Resources:
Slides
Webcast
AI for diagnosis and predictive biomarkers in thoracic oncology
Presenter: Paul Hofman
Session: AI application in diagnosis and pathology
Resources:
Slides
Webcast
How can we optimise the use of immunotherapy for driver+ NSCLC: Are all targets the same?
Presenter: Tony S.K. Mok
Session: Best therapies with driver mutations in lung cancer
Resources:
Slides
Webcast